TherapeuticsMD Inc. (NYSE MKT:TXMD), an innovative women’s healthcare company, announced today that positive results from phase 2 and pharmacokinetic studies of TX-004HR will be presented at the 25th Annual Meeting of The North American Menopause Society, October 15-18, 2014, at the Gaylord National Resort & Convention Center in Washington, D.C.
Help employers find you! Check out all the jobs and post your resume.
